Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1
The cytosolic thymidine kinase 1 (TK1) is one of the enzymes involved in DNA replication. Based on biochemical studies, TK1 is activated at late G1 of cell cycle, and its activity correlates with the cell proliferation. We have developed a polyclonal anti‐TK1 antibody against a synthetic peptide fro...
Main Authors: | Naining Wang, Qimin He, Sven Skog, Staffan Eriksson, Bernhard Tribukait |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2001-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2001/658312 |
Similar Items
-
Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume
by: Bernhard Tribukait
Published: (2020-05-01) -
Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker
by: Jianjun Wang, et al.
Published: (2017-06-01) -
Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
by: Johan Mattsson Ulfstedt, et al.
Published: (2021-08-01) -
Investigation of Thymidine Kinase 1 in Cancer Progression
by: Bitter, Eliza Esther King
Published: (2019) -
Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker
by: Liya Wang, et al.
Published: (2021-09-01)